World Pharma Newsfeed
AstraZeneca reaffirms December 2011 financial guidance for 2011
During a routine consensus collection process, confidential Company information was inadvertently embedded in a spreadsh...
Bristol-Myers Squibb to Acquire Inhibitex
Bristol-Myers Squibb Company (NYSE:BMY) and Inhibitex, Inc. (Nasdaq:INHX) have signed a definitive agreement under which...
Study finds statin costs 400 percent higher in US compared to UK
In the United States, the cost paid for statins (drugs to lower cholesterol) in people under the age of 65 who have priv...
Benefits of statin therapy may extend beyond lowering lipids
People with high cholesterol are at risk of heart attack and stroke because atherosclerotic plaques within their arterie...
Missing trial data threatens the integrity of medicine
Missing clinical trial data can harm patients and lead to futile costs to health systems, warn experts as part of an in-...
Hepatitis C virus hijacks liver microRNA
Viral diseases are still one of the biggest challenges to medical science. Thanks to thousands of years of co-evolution ...
Pfizer Receives FDA Approval to Extend Use of Prevnar 13®
Pfizer Inc. (NYSE:PFE) announced that the U.S. Food and Drug Administration (FDA) has granted approval of the Company's ...
Ovarian cancer study proves drug delays disease progression
Treating ovarian cancer with the drug bevacizumab ("Avastin") delays the disease and may also improve survival, show the...
Scientists Fixate on Ric-8 to Understand Trafficking of Popular Drug Receptor Targets
Half the drugs used today target a single class of proteins - and now scientists have identified an important molecular ...
Boehringer Ingelheim significantly expands its supply center for China
Boehringer Ingelheim intends to invest 70 million Euro to expand its manufacturing plant in the Zhangjiang High-Tech Par...
